Loading…
Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote
Abstract Background Long QT syndrome (LQTS) presents two clinical phenotypes, congenital and acquired forms. This study aims to evaluate the genetic contribution of a KCNH2 variant for the two LQTS phenotypes. Methods From 1996 to 2014, genetic screening for LQTS probands was performed for five majo...
Saved in:
Published in: | Journal of cardiology 2017-07, Vol.70 (1), p.74-79 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913 |
---|---|
cites | cdi_FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913 |
container_end_page | 79 |
container_issue | 1 |
container_start_page | 74 |
container_title | Journal of cardiology |
container_volume | 70 |
creator | Fujii, Yusuke, MD Matsumoto, Yuichi, MD Hayashi, Kenshi, MD, PhD, FJCC Ding, Wei-Guang, MD, PhD Tomita, Yukinori, MD Fukumoto, Daisuke, MD Wada, Yuko, MD Ichikawa, Mari, MD Sonoda, Keiko, MD Ozawa, Junichi, MD Makiyama, Takeru, MD, PhD Ohno, Seiko, MD, PhD Yamagishi, Masakazu, MD, PhD, FJCC Matsuura, Hiroshi, MD, PhD Horie, Minoru, MD, PhD Itoh, Hideki, MD, PhD, FJCC |
description | Abstract Background Long QT syndrome (LQTS) presents two clinical phenotypes, congenital and acquired forms. This study aims to evaluate the genetic contribution of a KCNH2 variant for the two LQTS phenotypes. Methods From 1996 to 2014, genetic screening for LQTS probands was performed for five major genes: KCNQ1 , KCNH2 , SCN5A , KCNE1 , and KCNE2 and 389 probands were found to be mutation carriers. We analyzed the clinical phenotypes of p.His492Tyr carriers in KCNH2. Results Heterozygous p.His492Tyr variant was identified in 10 LQTS families. Six probands (mean age, 26 ± 23 years) carried another mutation, and two of six had syncope associated with emotional stress or telephone ringing. The remaining four probands were significantly older at diagnosis (mean age, 42 ± 33 years) and carried no other compound mutations. All the four probands had fatal arrhythmic events in the presence of additional precipitating factors such as culprit drugs in 2, hypokalemia in 1, and bradycardia in 1. The QTc interval of carriers with p.His492Tyr alone was 445 ± 10 ms and significantly shorter than that in double mutation carriers (481 ± 40 ms, p = 0.041). Conclusions KCNH2 p.His492Tyr variant presented Romano–Ward syndrome in the presence of another mutation and heterozygous carriers had mild phenotypes while even heterozygous carriers should be cared for not to encounter secondary factors because incidental factors could manifest “latent” form of p.His492Tyr heterozygous carriers. |
doi_str_mv | 10.1016/j.jjcc.2016.09.010 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1837026805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0914508716302192</els_id><sourcerecordid>1837026805</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913</originalsourceid><addsrcrecordid>eNp9ks-K1TAUxosoznX0BVxIlm5aT_oviYgwXNQRB0UdcRnS5PSa2iZ3knagrnwH176cT2LLvc5CxFUO4fu-wzm_kyQPKWQUaP2ky7pO6yxf6gxEBhRuJRvKWZ2WrOC3kw0IWqYVcHaS3IuxA6hB8PpucpIzTuuCik3yc-vdGGwzjdY74luiyJvt2_OcXKtglRuJdWSHzo_zHg3pvduR95ckzs4EP-BT8sEPyvlf3398VsHc_JPJGQzE-KnpkQzTqNb4SJQzROmryYZ_hB1NX3DE4L_NOz_i_eROq_qID47vafLp5YvL7Xl68e7V6-3ZRaqrshpTXrVMUcVq2tSlElDwAhqgJeeIhWiBa8ZAtE1RgQbWGA261qyGFgukTNDiNHl8yN0HfzVhHOVgo8a-Vw79FCXlBYO85lAt0vwg1cHHGLCV-2AHFWZJQa5YZCdXLHLFIkHIBctienTMn5oBzY3lD4dF8OwgwGXKa4tBRm3RaTTLqvQojbf_z3_-l1331lmt-q84Y-z8FNyyP0llzCXIj-thrHexNIecirz4DeZstj4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1837026805</pqid></control><display><type>article</type><title>Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote</title><source>Elsevier</source><creator>Fujii, Yusuke, MD ; Matsumoto, Yuichi, MD ; Hayashi, Kenshi, MD, PhD, FJCC ; Ding, Wei-Guang, MD, PhD ; Tomita, Yukinori, MD ; Fukumoto, Daisuke, MD ; Wada, Yuko, MD ; Ichikawa, Mari, MD ; Sonoda, Keiko, MD ; Ozawa, Junichi, MD ; Makiyama, Takeru, MD, PhD ; Ohno, Seiko, MD, PhD ; Yamagishi, Masakazu, MD, PhD, FJCC ; Matsuura, Hiroshi, MD, PhD ; Horie, Minoru, MD, PhD ; Itoh, Hideki, MD, PhD, FJCC</creator><creatorcontrib>Fujii, Yusuke, MD ; Matsumoto, Yuichi, MD ; Hayashi, Kenshi, MD, PhD, FJCC ; Ding, Wei-Guang, MD, PhD ; Tomita, Yukinori, MD ; Fukumoto, Daisuke, MD ; Wada, Yuko, MD ; Ichikawa, Mari, MD ; Sonoda, Keiko, MD ; Ozawa, Junichi, MD ; Makiyama, Takeru, MD, PhD ; Ohno, Seiko, MD, PhD ; Yamagishi, Masakazu, MD, PhD, FJCC ; Matsuura, Hiroshi, MD, PhD ; Horie, Minoru, MD, PhD ; Itoh, Hideki, MD, PhD, FJCC</creatorcontrib><description>Abstract Background Long QT syndrome (LQTS) presents two clinical phenotypes, congenital and acquired forms. This study aims to evaluate the genetic contribution of a KCNH2 variant for the two LQTS phenotypes. Methods From 1996 to 2014, genetic screening for LQTS probands was performed for five major genes: KCNQ1 , KCNH2 , SCN5A , KCNE1 , and KCNE2 and 389 probands were found to be mutation carriers. We analyzed the clinical phenotypes of p.His492Tyr carriers in KCNH2. Results Heterozygous p.His492Tyr variant was identified in 10 LQTS families. Six probands (mean age, 26 ± 23 years) carried another mutation, and two of six had syncope associated with emotional stress or telephone ringing. The remaining four probands were significantly older at diagnosis (mean age, 42 ± 33 years) and carried no other compound mutations. All the four probands had fatal arrhythmic events in the presence of additional precipitating factors such as culprit drugs in 2, hypokalemia in 1, and bradycardia in 1. The QTc interval of carriers with p.His492Tyr alone was 445 ± 10 ms and significantly shorter than that in double mutation carriers (481 ± 40 ms, p = 0.041). Conclusions KCNH2 p.His492Tyr variant presented Romano–Ward syndrome in the presence of another mutation and heterozygous carriers had mild phenotypes while even heterozygous carriers should be cared for not to encounter secondary factors because incidental factors could manifest “latent” form of p.His492Tyr heterozygous carriers.</description><identifier>ISSN: 0914-5087</identifier><identifier>EISSN: 1876-4738</identifier><identifier>DOI: 10.1016/j.jjcc.2016.09.010</identifier><identifier>PMID: 27816319</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Acquired long QT syndrome ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Bradycardia-induced long QT syndrome ; Cardiovascular ; Child ; Child, Preschool ; Drug-induced long QT syndrome ; Electrocardiography ; ERG1 Potassium Channel - genetics ; Female ; Genetic Testing ; Genotype ; Heterozygote ; Humans ; Hypokalemia - genetics ; Hypokalemia-induced long QT syndrome ; KCNH2 ; Long QT Syndrome - genetics ; Male ; Middle Aged ; Mutation ; Phenotype ; Young Adult</subject><ispartof>Journal of cardiology, 2017-07, Vol.70 (1), p.74-79</ispartof><rights>Japanese College of Cardiology</rights><rights>2016 Japanese College of Cardiology</rights><rights>Copyright © 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913</citedby><cites>FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913</cites><orcidid>0000-0003-3572-0836</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27816319$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fujii, Yusuke, MD</creatorcontrib><creatorcontrib>Matsumoto, Yuichi, MD</creatorcontrib><creatorcontrib>Hayashi, Kenshi, MD, PhD, FJCC</creatorcontrib><creatorcontrib>Ding, Wei-Guang, MD, PhD</creatorcontrib><creatorcontrib>Tomita, Yukinori, MD</creatorcontrib><creatorcontrib>Fukumoto, Daisuke, MD</creatorcontrib><creatorcontrib>Wada, Yuko, MD</creatorcontrib><creatorcontrib>Ichikawa, Mari, MD</creatorcontrib><creatorcontrib>Sonoda, Keiko, MD</creatorcontrib><creatorcontrib>Ozawa, Junichi, MD</creatorcontrib><creatorcontrib>Makiyama, Takeru, MD, PhD</creatorcontrib><creatorcontrib>Ohno, Seiko, MD, PhD</creatorcontrib><creatorcontrib>Yamagishi, Masakazu, MD, PhD, FJCC</creatorcontrib><creatorcontrib>Matsuura, Hiroshi, MD, PhD</creatorcontrib><creatorcontrib>Horie, Minoru, MD, PhD</creatorcontrib><creatorcontrib>Itoh, Hideki, MD, PhD, FJCC</creatorcontrib><title>Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote</title><title>Journal of cardiology</title><addtitle>J Cardiol</addtitle><description>Abstract Background Long QT syndrome (LQTS) presents two clinical phenotypes, congenital and acquired forms. This study aims to evaluate the genetic contribution of a KCNH2 variant for the two LQTS phenotypes. Methods From 1996 to 2014, genetic screening for LQTS probands was performed for five major genes: KCNQ1 , KCNH2 , SCN5A , KCNE1 , and KCNE2 and 389 probands were found to be mutation carriers. We analyzed the clinical phenotypes of p.His492Tyr carriers in KCNH2. Results Heterozygous p.His492Tyr variant was identified in 10 LQTS families. Six probands (mean age, 26 ± 23 years) carried another mutation, and two of six had syncope associated with emotional stress or telephone ringing. The remaining four probands were significantly older at diagnosis (mean age, 42 ± 33 years) and carried no other compound mutations. All the four probands had fatal arrhythmic events in the presence of additional precipitating factors such as culprit drugs in 2, hypokalemia in 1, and bradycardia in 1. The QTc interval of carriers with p.His492Tyr alone was 445 ± 10 ms and significantly shorter than that in double mutation carriers (481 ± 40 ms, p = 0.041). Conclusions KCNH2 p.His492Tyr variant presented Romano–Ward syndrome in the presence of another mutation and heterozygous carriers had mild phenotypes while even heterozygous carriers should be cared for not to encounter secondary factors because incidental factors could manifest “latent” form of p.His492Tyr heterozygous carriers.</description><subject>Acquired long QT syndrome</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Bradycardia-induced long QT syndrome</subject><subject>Cardiovascular</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Drug-induced long QT syndrome</subject><subject>Electrocardiography</subject><subject>ERG1 Potassium Channel - genetics</subject><subject>Female</subject><subject>Genetic Testing</subject><subject>Genotype</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Hypokalemia - genetics</subject><subject>Hypokalemia-induced long QT syndrome</subject><subject>KCNH2</subject><subject>Long QT Syndrome - genetics</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Phenotype</subject><subject>Young Adult</subject><issn>0914-5087</issn><issn>1876-4738</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9ks-K1TAUxosoznX0BVxIlm5aT_oviYgwXNQRB0UdcRnS5PSa2iZ3knagrnwH176cT2LLvc5CxFUO4fu-wzm_kyQPKWQUaP2ky7pO6yxf6gxEBhRuJRvKWZ2WrOC3kw0IWqYVcHaS3IuxA6hB8PpucpIzTuuCik3yc-vdGGwzjdY74luiyJvt2_OcXKtglRuJdWSHzo_zHg3pvduR95ckzs4EP-BT8sEPyvlf3398VsHc_JPJGQzE-KnpkQzTqNb4SJQzROmryYZ_hB1NX3DE4L_NOz_i_eROq_qID47vafLp5YvL7Xl68e7V6-3ZRaqrshpTXrVMUcVq2tSlElDwAhqgJeeIhWiBa8ZAtE1RgQbWGA261qyGFgukTNDiNHl8yN0HfzVhHOVgo8a-Vw79FCXlBYO85lAt0vwg1cHHGLCV-2AHFWZJQa5YZCdXLHLFIkHIBctienTMn5oBzY3lD4dF8OwgwGXKa4tBRm3RaTTLqvQojbf_z3_-l1331lmt-q84Y-z8FNyyP0llzCXIj-thrHexNIecirz4DeZstj4</recordid><startdate>20170701</startdate><enddate>20170701</enddate><creator>Fujii, Yusuke, MD</creator><creator>Matsumoto, Yuichi, MD</creator><creator>Hayashi, Kenshi, MD, PhD, FJCC</creator><creator>Ding, Wei-Guang, MD, PhD</creator><creator>Tomita, Yukinori, MD</creator><creator>Fukumoto, Daisuke, MD</creator><creator>Wada, Yuko, MD</creator><creator>Ichikawa, Mari, MD</creator><creator>Sonoda, Keiko, MD</creator><creator>Ozawa, Junichi, MD</creator><creator>Makiyama, Takeru, MD, PhD</creator><creator>Ohno, Seiko, MD, PhD</creator><creator>Yamagishi, Masakazu, MD, PhD, FJCC</creator><creator>Matsuura, Hiroshi, MD, PhD</creator><creator>Horie, Minoru, MD, PhD</creator><creator>Itoh, Hideki, MD, PhD, FJCC</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3572-0836</orcidid></search><sort><creationdate>20170701</creationdate><title>Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote</title><author>Fujii, Yusuke, MD ; Matsumoto, Yuichi, MD ; Hayashi, Kenshi, MD, PhD, FJCC ; Ding, Wei-Guang, MD, PhD ; Tomita, Yukinori, MD ; Fukumoto, Daisuke, MD ; Wada, Yuko, MD ; Ichikawa, Mari, MD ; Sonoda, Keiko, MD ; Ozawa, Junichi, MD ; Makiyama, Takeru, MD, PhD ; Ohno, Seiko, MD, PhD ; Yamagishi, Masakazu, MD, PhD, FJCC ; Matsuura, Hiroshi, MD, PhD ; Horie, Minoru, MD, PhD ; Itoh, Hideki, MD, PhD, FJCC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acquired long QT syndrome</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Bradycardia-induced long QT syndrome</topic><topic>Cardiovascular</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Drug-induced long QT syndrome</topic><topic>Electrocardiography</topic><topic>ERG1 Potassium Channel - genetics</topic><topic>Female</topic><topic>Genetic Testing</topic><topic>Genotype</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Hypokalemia - genetics</topic><topic>Hypokalemia-induced long QT syndrome</topic><topic>KCNH2</topic><topic>Long QT Syndrome - genetics</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Phenotype</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fujii, Yusuke, MD</creatorcontrib><creatorcontrib>Matsumoto, Yuichi, MD</creatorcontrib><creatorcontrib>Hayashi, Kenshi, MD, PhD, FJCC</creatorcontrib><creatorcontrib>Ding, Wei-Guang, MD, PhD</creatorcontrib><creatorcontrib>Tomita, Yukinori, MD</creatorcontrib><creatorcontrib>Fukumoto, Daisuke, MD</creatorcontrib><creatorcontrib>Wada, Yuko, MD</creatorcontrib><creatorcontrib>Ichikawa, Mari, MD</creatorcontrib><creatorcontrib>Sonoda, Keiko, MD</creatorcontrib><creatorcontrib>Ozawa, Junichi, MD</creatorcontrib><creatorcontrib>Makiyama, Takeru, MD, PhD</creatorcontrib><creatorcontrib>Ohno, Seiko, MD, PhD</creatorcontrib><creatorcontrib>Yamagishi, Masakazu, MD, PhD, FJCC</creatorcontrib><creatorcontrib>Matsuura, Hiroshi, MD, PhD</creatorcontrib><creatorcontrib>Horie, Minoru, MD, PhD</creatorcontrib><creatorcontrib>Itoh, Hideki, MD, PhD, FJCC</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fujii, Yusuke, MD</au><au>Matsumoto, Yuichi, MD</au><au>Hayashi, Kenshi, MD, PhD, FJCC</au><au>Ding, Wei-Guang, MD, PhD</au><au>Tomita, Yukinori, MD</au><au>Fukumoto, Daisuke, MD</au><au>Wada, Yuko, MD</au><au>Ichikawa, Mari, MD</au><au>Sonoda, Keiko, MD</au><au>Ozawa, Junichi, MD</au><au>Makiyama, Takeru, MD, PhD</au><au>Ohno, Seiko, MD, PhD</au><au>Yamagishi, Masakazu, MD, PhD, FJCC</au><au>Matsuura, Hiroshi, MD, PhD</au><au>Horie, Minoru, MD, PhD</au><au>Itoh, Hideki, MD, PhD, FJCC</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote</atitle><jtitle>Journal of cardiology</jtitle><addtitle>J Cardiol</addtitle><date>2017-07-01</date><risdate>2017</risdate><volume>70</volume><issue>1</issue><spage>74</spage><epage>79</epage><pages>74-79</pages><issn>0914-5087</issn><eissn>1876-4738</eissn><abstract>Abstract Background Long QT syndrome (LQTS) presents two clinical phenotypes, congenital and acquired forms. This study aims to evaluate the genetic contribution of a KCNH2 variant for the two LQTS phenotypes. Methods From 1996 to 2014, genetic screening for LQTS probands was performed for five major genes: KCNQ1 , KCNH2 , SCN5A , KCNE1 , and KCNE2 and 389 probands were found to be mutation carriers. We analyzed the clinical phenotypes of p.His492Tyr carriers in KCNH2. Results Heterozygous p.His492Tyr variant was identified in 10 LQTS families. Six probands (mean age, 26 ± 23 years) carried another mutation, and two of six had syncope associated with emotional stress or telephone ringing. The remaining four probands were significantly older at diagnosis (mean age, 42 ± 33 years) and carried no other compound mutations. All the four probands had fatal arrhythmic events in the presence of additional precipitating factors such as culprit drugs in 2, hypokalemia in 1, and bradycardia in 1. The QTc interval of carriers with p.His492Tyr alone was 445 ± 10 ms and significantly shorter than that in double mutation carriers (481 ± 40 ms, p = 0.041). Conclusions KCNH2 p.His492Tyr variant presented Romano–Ward syndrome in the presence of another mutation and heterozygous carriers had mild phenotypes while even heterozygous carriers should be cared for not to encounter secondary factors because incidental factors could manifest “latent” form of p.His492Tyr heterozygous carriers.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>27816319</pmid><doi>10.1016/j.jjcc.2016.09.010</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-3572-0836</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0914-5087 |
ispartof | Journal of cardiology, 2017-07, Vol.70 (1), p.74-79 |
issn | 0914-5087 1876-4738 |
language | eng |
recordid | cdi_proquest_miscellaneous_1837026805 |
source | Elsevier |
subjects | Acquired long QT syndrome Adolescent Adult Aged Aged, 80 and over Bradycardia-induced long QT syndrome Cardiovascular Child Child, Preschool Drug-induced long QT syndrome Electrocardiography ERG1 Potassium Channel - genetics Female Genetic Testing Genotype Heterozygote Humans Hypokalemia - genetics Hypokalemia-induced long QT syndrome KCNH2 Long QT Syndrome - genetics Male Middle Aged Mutation Phenotype Young Adult |
title | Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T00%3A30%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contribution%20of%20a%20KCNH2%20variant%20in%20genotyped%20long%20QT%20syndrome:%20Romano%E2%80%93Ward%20syndrome%20under%20double%20mutations%20and%20acquired%20long%20QT%20syndrome%20under%20heterozygote&rft.jtitle=Journal%20of%20cardiology&rft.au=Fujii,%20Yusuke,%20MD&rft.date=2017-07-01&rft.volume=70&rft.issue=1&rft.spage=74&rft.epage=79&rft.pages=74-79&rft.issn=0914-5087&rft.eissn=1876-4738&rft_id=info:doi/10.1016/j.jjcc.2016.09.010&rft_dat=%3Cproquest_cross%3E1837026805%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1837026805&rft_id=info:pmid/27816319&rfr_iscdi=true |